Valeant, Akorn Power Drugmakers Up IBD Industry Ranks

By | December 3, 2013

Scalper1 News

A handful of top-rated stocks have powered the Medical-Ethical Drugs industry into the upper echelon of IBD’s 197 industry groups. The 42-member contingent, which includes IBD 50 members Akorn (AKRX), Valeant Pharmaceuticals (VRX), Jazz Pharmaceuticals (JAZZ) and Salix Pharmaceuticals (SLXP), was ranked 8th as of Tuesday’s IBD. That’s up from 21st just six weeks ago. Most of these stocks have already enjoyed big runs and are well out of buying Scalper1 News

Scalper1 News